Skip to main content
. 2026 Jan 21;14(1):236. doi: 10.3390/biomedicines14010236
ACEIs Angiotensin Converting Enzyme inhibitors
ARBs Aldosterone Receptors Blockers
CKD Chronic Kidney Diseases
CMJAH Charlotte Maxeke Johannesburg Academic Hospital
CKD-EPI Chronic Kidney Disease Epidemiology Collaboration
ESKD End-Stage Kidney Disease
T2DM Type 2 Diabetes Mellitus
TGF-β Transforming Growth Factor-β
eGFR Estimated Glomerular Filtration Rate
IDMS Isotope Dilution Mass Spectroscopy
uPCR Urine Protein Creatinine Ratio
CCBs Calcium Channel Blockers
KDIGO Kidney Disease Improving Global Outcomes
NCDs Non-Communicable Diseases